Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti-Cd19-Car Γδt
Immune Thrombocytopenia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Anti-Cd19-Car Γδt
Primary Biliary Cholangitis
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Anti-Cd19-Car Γδt
Rheumatoid Arthritis
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Anti-Cd19-Car Γδt
Sjogren's Syndrome
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Anti-Cd19-Car Γδt
Systemic Lupus Erythematosus
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Anti-Cd19-Car Γδt
Systemic Sclerosis
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Anti-Cd20/Cd30-Car-T Cells
B Cell Malignancies
Shanghai Tongji Hospital, Tongji University School of Medicine
Early P1
C
(39)
Anti-Cd20/Cd30-Car-T Cells
Relapsed/Refractory Leukemia
Affiliated Hospital of Nantong University
Early P1
C
(39)
Anti-Cd20/Cd30-Car-T Cells
Relapsed/Refractory Lymphoma
Affiliated Hospital of Nantong University
Early P1
C
(39)
Anti Cd30 Car-T Cell
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Anti Cd30 Car-T Cell
Primary Mediastinal Large B-Cell Lymphoma
Zhejiang University
Early P1
C
(39)
Anti Cd30 Car-T Cell
Extranodal Nasal NK/T Cell Lymphoma
Zhejiang University
Early P1
C
(39)
Anti Cd30 Car-T Cell
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Zhejiang University
Early P1
C
(39)
Anti-Cdh17 Car-T Cells
CDH17-positive Advanced Solid Tumors
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Early P1
C
(39)
Anti-Ex02 Car T Cells
Biliary Tract Cancer
Zhang Xiaofeng,MD
Early P1
C
(39)
Anti-Psma Car-Nk
Castration-Resistant Prostate Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early P1
C
(39)
Apple Cider Vinegar
Bone Diseases
Western University
Early P1
C
(39)
Apple Cider Vinegar
Hyperlipidemia
Western University
Early P1
C
(39)
April Car-T Cells
Plasma Cell Myeloma
Zhejiang University
Early P1
C
(39)
ARA-GUANOSINE
PASC Post Acute Sequelae of COVID-19
University of California, Davis
Early P1
C
(39)
ARG
Neuroendocrine Tumor Grade 1
David Bushnell
Early P1
C
(39)
ARG
Neuroendocrine Tumor of the Lung
David Bushnell
Early P1
C
(39)
Arimidex
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Arimidex
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Arimidex
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Showing 226 to 250 of 1,553 assets
Previous
Page 10 of 63
Next
